Canning
Since 1965 we have helped people like you to communicate more effectively while doing business across borders. The worldwide web is full of companies offering to do these things for you. What makes us different? Explore our website and have a look. Or, even better, contact us and talk to one of our team about what we could do for you and your organisation. Our existing clients know we are the best. You need to discover that for yourself.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
M3 (EU)
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
07 Good Pharma
White Papers and Resources | January 3, 2014 | Havas Lynx
Better for patients, better for business
06 Our Opportunity to Rethink the Health Experience
White Papers and Resources | January 3, 2014 | Havas Lynx
Our point of view
05 Social Media: A Health Hazard?
White Papers and Resources | January 3, 2014 | Havas Lynx
The case to embrace going social
Creating a Lifeline to the New Digital User
White Papers and Resources | January 3, 2014 | Havas Lynx
Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...
Warehousing of HCV patients reaches new high
White Papers and Resources | December 19, 2013 | Inizio
A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...
Brand leaders in RA will lose market share, predict rheumatologists
White Papers and Resources | December 19, 2013 | Inizio
Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.
Removing the Roadblocks to Effective Patient Treatment
White Papers and Resources | November 22, 2013 | Inizio
How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...
Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis
White Papers and Resources | November 22, 2013 | Inizio
Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards...
The Difficulties of Living with Depression Don’t End with the Illness Itself
White Papers and Resources | November 22, 2013 | Inizio
This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.
Patient Power: Too Much of a Good Thing?
White Papers and Resources | November 22, 2013 | Inizio
Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding